George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,653.00
Bid: 1,654.00
Ask: 1,654.50
Change: 12.50 (0.76%)
Spread: 0.50 (0.03%)
Open: 1,638.50
High: 1,655.50
Low: 1,634.00
Prev. Close: 1,640.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: Vouchers, Grocers, Boohoo

Sun, 05th Jul 2020 15:59

(Sharecast News) - Radical plans to give all adults £500 and children £250 in vouchers to spend in sectors of the economy worst hit by the Covid-19 crisis are being considered by the Treasury. The proposals, drawn up by the Resolution Foundation think tank, which has had recent talks with the Treasury about its ideas, are aimed at kickstarting economic recovery by triggering a highly targeted surge in spending. Under the plans the vouchers could only be spent in certain sectors, such as hospitality and "face to face" retail, as opposed to online. - Guardian

Britain's grocers are gearing up for a massive price war amidst fears unemployment could rise above four million. More than 14,000 jobs were lost this week as a coronavirus jobs bloodbath hit the economy. The jobs cull has left supermarket bosses scrambling to show they are competitive on price as household budgets are squeezed due to the crisis. They are worried that the German discounters Aldi and Lidl will repeat the sort of market-share gains made after the 2008 financial crash. - Mail on Sunday

Workers in Leicester making clothes destined for the fashion giant Boohoo are being paid as little as £3.50 an hour, an undercover Sunday Times investigation has found. [...] The undercover reporter spent two days working in the factory where he was told to expect £3.50 an hour, despite the minimum wage in Britain for those aged 25 and over being £8.72. He obtained covert video footage of himself packing garments made in the factory under the label of Nasty Gal, which is owned by the fast-fashion brand Boohoo whose boss, Mahmud Kamani, is set to scoop a £50m bonus. - Sunday Times

Employers planning mass redundancies of furloughed workers face restrictions that may force them to pay back months of wages to the taxpayer. The Treasury has panicked some businesses by rewording the purpose of the Coronavirus Job Retention Scheme to say it is "integral" that its money is "used by the employer to continue the employment of employees". The change, unveiled last week, has meanwhile sparked hopes among 
 campaigners that employers will think twice before laying off swathes of Britain's 9.3 million furloughed workforce. - Sunday Telegraph

Glaxo Smith Kline and Sanofi are close to agreeing a £500m deal to supply the British government with 60 million doses of their coronavirus vaccine. The business department is understood to be taking an option to buy the vaccine from the pharmaceuticals giants should it work in human trials, which are due to begin in September. The deal for an as yet unproven vaccine underlines ministers' desperation to secure a supply as countries scramble to buy up possible Covid-19 treatments. - Sunday Times

Rolls-Royce is preparing to close its final salary pension scheme four years early to conserve cash as grounded aircraft pile pressure on its finances. The jet engine maker is seeking to end accrual of future benefits now, rather than in 2024. If Rolls gets the go-ahead from pension members and trustees following a consultation, it is likely to save a total of about £500m in contributions. Under the current arrangements, in the last financial year Rolls made total cash contributions to the pension scheme of more than £150m. - Sunday Telegraph

Bank of England governor Andrew Bailey has written to lenders warning them of the challenges negative interest rates would bring. Bailey, who succeeded Mark Carney as the virus crisis was taking hold in March, said that adapting to an unprecedented move into negative territory, where the Bank would charge commercial lenders to store reserves, would be "a significant operational undertaking for firms". He noted that many would need 12 months to change computer systems, update financial contracts designed for a world of positive interest rates and work out how to communicate with clients. - Sunday Times

The Panelbase survey also shows a commanding lead for the SNP heading into next year's Holyrood elections, with a resounding victory for Nicola Sturgeon likely to heighten calls for a second referendum on independence. Support for Scottish independence stands at 54% according to Panelbase poll for the Sunday Times, with 46% support for the union. It is the second survey in recent weeks to show this level of support among Scots for leaving the UK. - The Scotsman
More News
15 Dec 2023 17:08

European shares end fifth week higher on rate-cut optimism

Barclays sees first ECB rate cut in April

*

Read more
15 Dec 2023 16:51

LONDON MARKET CLOSE: FTSE 100 underperforms as post-Fed rally cools

(Alliance News) - London's FTSE 100 ended lower on Friday, with profit-taking and some hawkish words from a US policymaker keeping equities in check at the end of a largely positive week for stocks.

Read more
15 Dec 2023 16:29

PRESS: GSK, Astra and AbbVie in US scrutiny over patents - Bloomberg

(Alliance News) - A US senator has accused AstraZeneca PLC, GSK PLC, AbbVie Inc and other drugmakers of "abusing" the patent system to send prices higher, Bloomberg reported on Thursday.

Read more
12 Dec 2023 10:08

AstraZeneca buys respiratory vaccine developer Icosavax in $1.1 bln deal

Dec 12 (Reuters) - AstraZeneca said on Tuesday it had agreed to buy respiratory syncytial virus (RSV) vaccine developer Icosavax in a deal valued at up to $1.1 billion.

Read more
12 Dec 2023 08:22

TOP NEWS: Japan accepts GSK's filing for respiratory disease vaccine

(Alliance News) - GSK PLC on Tuesday said Japan's Ministry of Health, Labour & Welfare has accepted its regulatory application for the extension of its respiratory syncytial virus vaccine, Arexvy, for adults aged 50-59.

Read more
12 Dec 2023 07:39

LONDON BRIEFING: UK unemployment unchanged at 4.2%; eyes on US CPI

(Alliance News) - Stocks in London are called to open higher, as investors digest the latest UK unemployment data, before turning their heads to US inflation.

Read more
12 Dec 2023 07:24

GSK seeks to extend RSV vaccine approval in Japan

(Sharecast News) - GSK announced on Tuesday that Japan's Ministry of Health, Labour and Welfare (MHLW) has accepted its regulatory application for the extension of the indication of its RSV vaccine to include adults aged 50- to 59 at an increased risk of contracting the disease.

Read more
11 Dec 2023 08:28

GSK drug gets EU marketing backing for form of endometrial cancer

(Alliance News) - GSK PLC on Monday said it won EU backing for its Jemperli drug in tandem with chemotherapy to treat a form of endometrial cancer.

Read more
11 Dec 2023 07:41

LONDON BRIEFING: GSK drug gets EU endorsement; Begbies backs outlook

(Alliance News) - London's FTSE 100 is called to open a touch lower on Monday, kicking off the week with some slight trepidation after Friday's hotter-than-expected US jobs report which offered the dollar some respite.

Read more
11 Dec 2023 07:23

GSK endometrial cancer treatment gets Europe authorisation

(Sharecast News) - GSK announced on Monday that the European Commission has granted marketing authorisation for 'Jemperli', or dostarlimab, in combination with chemotherapy for certain endometrial cancers.

Read more
7 Dec 2023 12:54

THG backer Kelso pushes for demerger to trim "inherent" valuation gap

(Alliance News) - THG PLC investor Kelso Group Holdings PLC on Thursday reiterated its call for a demerger, which the shareholder believes will help close the "disparity" between the e-commerce firm's share price and its true value.

Read more
5 Dec 2023 10:02

LONDON BROKER RATINGS: Goldman lifts Landsec and British Land

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
27 Nov 2023 09:00

GSK announces positive results from Blenrep phase 3 blood cancer trial

(Alliance News) - GSK PLC on Monday said a phase 3 trial of belantamab mafodotin as a multiple myeloma treatment has produced positive headline results.

Read more
27 Nov 2023 08:02

GSK receives 'positive' headline results from phase III trial

(Sharecast News) - Drugmaker GSK announced on Monday that it had received positive headline results from a planned interim efficacy analysis from a phase III trial evaluating its elantamab mafodotin asset.

Read more
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.